Methods and device for treating opioid addiction
AssigneeTitan Pharmaceuticals, Inc.
InventorRajesh Patel
Life of this patent
Estimating the term…
Abstract
The invention described herein solves the challenges encountered in providing a safe, efficacious, and satisfactory option for the treatment of opioid addiction. Methods and devices of the invention allow a subject to receive an implantable formulation comprising an opioid receptor ligand, buprenorphine, or a metabolite thereof as a treatment for opioid addiction. The invention preempts several difficulties encountered with conventional methods for the treatment of opioid addiction, and by doing so the invention improves treatment adherence, compliance, patient satisfaction, and overall success rate.
Claims30
A method of treating hydrocodone addiction in a subject in need of relief thereof, the method comprising implanting into a subdermal tissue of the subject a device comprising at least one opioid receptor ligand and a polymer matrix, and subsequently sublingually administering the opioid receptor ligand to the subject, wherein the device releases a therapeutically-effective amount of the opioid receptor ligand.
Dependencies are inferred from the claim text.